Analysis of experience and prospects of mangiferin use in medicine and pharmacy
DOI:
https://doi.org/10.5281/zenodo.7721743Abstract
Aim. Analysis of literature data and determination of the therapeutic potential of mangiferin and prospects for its use in medicine and pharmacy. Materials and methods. Electronic sources of information and a number of scientific publications of domestic and foreign scientists were used as research materials. The analysis was carried out on the basis of electronic databases for the period 2002-2022, which formed the empirical basis of the study. Logical, system-analytical, structural-functional and comparative methods of analysis were used. Results and discussion. Mangiferin is a biologically active ingredient, which is mainly isolated from the mango tree, has potent multifactorial pharmacological effects, including antioxidant, antidiabetic, antitumor, cardioprotective, neuroprotective, anti-inflammatory, antibacterial, antiviral and immunomodulatory effects. However, its low solubility and bioavailability limit the oral use of mangiferin as a clinical therapeutic agent, and chemical and physical modification is required to expand its use. Studies have shown the ability of mangiferin to penetrate through the stratum corneum and pass into the epidermis and dermis, which indicates the feasibility of using mangiferin in preparations for topical use. Conclusions.A significant number of published scientific studies conducted in vitro and in vivo confirm the diverse properties of mangiferin and that mangiferin has a high potential for use as an active pharmaceutical ingredient in the pharmaceutical industry and is promising for the development of new dosage forms and their further research.
Keywords: mangiferin, antioxidant properties, antiviral activity, sources of mangiferin, application.
References
Pleguezuelos-Villa M, Nácher A, Hernández MJ et al. Mangiferin Nanoemulsions in treatment of Inflammatory Disorders and Skin Regeneration. International Journal of Pharmaceutics. 2019. Vol. 564. P. 299-307. DOI: 10.1016/j.ijpharm.2019.04.056.
Islam R, Bloch MB, Chamcheu R-CN et al. Anticancer properties of graviola (Annona Muricata): a comprehensive mechanistic review. Oxidative Medicine and Cellular Longevity. 2018. Vol. 2018. P. 1826170. DOI: 10.1155/2018/1826170.
Fujii A, Tetsuya O, Koji W et al. Identification of anti-inflammatory constituents in Phellodendri cortex and Coptidis rhizoma by monitoring the suppression of nitric oxide production. J. Nat. Med. 2017. Vol. 71 (4). P. 745–756. DOI:10.1007/s11418-017-1107-4.
Khazdair MR, Ghorani V, Alavinezhad A et al. Pharmacological effects of Zataria multiflora Boiss L. and its constituents focus on their anti-inflammatory, antioxidant, and immunomodulatory effects. Fundam. Clin. Pharmacol. 2018. Vol. 32 (1). P. 26–50. DOI: 10.1111/fcp.12331.
Strus O, Polovko N, Plaskonis Y. The investigation of the development of a cream composition with the sapropel extract. Asian Journal of Pharmaceutical and Clinical Research. 2018. Vol. 11 (7). P. 147–150. DOI:10.22159/ajpcr.2018.v11i7.23575.
Okafo SE, Chukwu A. Studies on sida acuta hydrogel I: Processing and physicochemical properties of the derived hydrogel obtained from South East Nigeria. Int J Pharm Pharm Sci. 2017. Vol. 9. P. 5-11. DOI: 10.22159/ijpps.2017v9i6.10097.
Bhardwaj A, Modi KP. Pharmacognostical screening and determination of antioxidant activity of Nelumbo nucifera Gaertn ethanol seed extract by different in vitro models. Int J Pharm Pharm Sci. 2017. Vol. 9. P. 64-70. DOI: 10.22159/ijpps.2017v9i3.16362.
Deng S, Cheng J, Jinmin Z et al. Natural compounds for the treatment of psoriatic arthritis: a proposal based on multi-targeted osteoclastic regulation and on a preclinical study. Res. Protocols. 2017. Vol. 6 (7). P. e132. DOI: 10.2196/resprot.7636.
Deng S, May BH, Zhang AL et al. Topical herbal formulae in the management of psoriasis: systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs. Phytotherapy Res. 2014. Vol. 28 (4). P. 480–497. DOI: 10.2196/resprot.7636.
Liu K, Wu L, Shi X, Wu F. Protective effect of naringin against ankylosing spondylitis via ossification, inflammation and oxidative stress in mice. Exp. Therapeutic Medicine. 2016. Vol. 12 (2). P. 1153–1158. DOI: 10.3892/etm.2016.3410.
Sheng X, Wang J, Guo J et al. Effects of baicalin on diabetic cardiac autonomic neuropathy mediated by the P2Y12 receptor in rat stellate ganglia. Cell. Physiol. Biochem. 2018. Vol. 46 (3). P. 986–998. DOI: 10.1159/000488828.
Zhao L, Fang C, Feng T et al. Combination treatment with quercetin and resveratrol attenuates high fat diet-induced obesity and associated inflammation in rats via the AMPKα1/SIRT1 signaling pathway. Exp. Therapeutic Med. 2017. Vol. 14 (6). P. 5942–5948. DOI: 10.3892/etm.2017.5331.
Mir-Palomo S, Nácher A, Díez-Sales O et al. Inhibition of skin inflammation by baicalin ultradeformable vesicles. Int. J. Pharm. 2016. Vol. 511 (1). P. 23–29. DOI: 10.1016/j.ijpharm.2016.06.136.
Pleguezuelos-Villa M, Mir-Palomo S, Díez-Sales O et al. A novel ultradeformable liposomes of naringin for anti-inflammatory therapy. Colloids and Surfaces. B, Biointerfaces 2018. Vol. 162. P. 265–270. DOI: 10.1016/j.colsurfb.2017.11.068.
Imran M, Arshad MS, Butt MS et al. Mangiferin: a natural miracle bioactive compound against lifestyle related disordersLipids Health Dis. 2017. Vol. 16. P. 84. DOI: 10.1186/s12944-017-0449-y.
Zhao Y, Wang W, Wu X et al. Mangiferin antagonizes TNF-α-mediated inflammatory reaction and protects against dermatitis in a mice model. Int. Immunopharmacol. 2017. Vol. 45. P. 174–179. DOI: 10.1016/j.intimp.2017.02.014.
Ochocka R, Hering A, Stefanowicz-Hajduk J et al. The effect of mangiferin on skin: Penetration, permeation and inhibition of ECM enzymes. PLoS One. 2017. Vol. 12 (7). P. e0181542. DOI: 10.1371/journal.pone.0181542.
Matkowski A, Kuś P, Góralska E, Woźniak D. Mangiferin - a bioactive xanthonoid, not only from mango and not just antioxidant. Mini Rev Med Chem. 2013. Vol. 13 (3). P. 439-455.
Korkina LG. Phenylpropanoids as naturally occurring antioxidants: From plant defense to human health. Cellular and Molecular Biology. 2007. Vol. 53 (1). P. 15-25.
Benard O, Chi Y. Medicinal Properties of Mangiferin, Structural Features, Derivative Synthesis, Pharmacokinetics and Biological Activities. Mini reviews in medicinal chemistry. 2015. Vol. 15 (7). P. 582-594. DOI: 10.2174/1389557515666150401111410.
Zolotareva OK, Podorvanov VV, Dubyna DV. Polyphenolic compounds of macrophytes and their ecological importance. Ukr. Bot. J. 2017. Vol. 74 (4). P. 373–384. DOI: 10.15407/ukrbotj74.04.373.
Gabr AMM, Mabrok HB, Sytar O, Smetanska I. Recent advances toward development of plant cell culture process for sustainable production of lignans and their health benefits. In: Malik S. (eds). Exploring Plant Cells for the Production of Compounds of Interest. Springer, Cham., 2021. DOI: https://doi.org/10.1007/978-3-030-58271-5_10.
Isaev DI, Kerimov UB, Kovalyov SV, Zatylnikova OO. Xanthones from rhizomes of Iris ibricata Lindl. and Iris pseudacorus L. Pharmacom. 2009. Vol. 4. P. 24-28.
Du S, Liu H, Lei T et al. Mangiferin: An effective therapeutic agent against several disorders (Review). Mol Med. 2018. Vol. 18 (6). P. 775-786. DOI: 10.3892/mmr.2018.9529.
Krechun AV. Study of biologically active substances of Hungarian roosters and development of substances based on them. Dissertation. Kharkiv, 2020. 250 p.
Maji HS, Maji S, Roy R, et al. Isolation of mangiferin from flowering buds of mangifera indica l and its evaluation of in vitro antibacterial activity. JPA. 2015. Vol. 4. P. 49-56.
Iseda S. On Mangiferin, the Coloring Matter of Mango (Mangifera-Indica Linn.). V. Identification of Sugar Component and the Structure of Mangiferin. Bulletin of the Chemical Society of Japan. 1957 . Vol. 30 (6). P. 629-633. DOI: 10.1246/bcsj.30.629.
Ajila CM, Rao LJ, Rao UJSP. Characterization of bioactive compounds from raw and ripe Mangifera indica L. peel extracts. Food and Chemical Toxicology. 2010. Vol. 48 (12). P. 3406-3411. DOI: 10.1016/j.fct.2010.09.012.
Qin JP, Deng JG, Feng X et al. Quantitative RP-LC Analysis of Mangiferin and Homomangiferin in Mangifera indica L. Leaves and in Mangifera persiciforma CY Wu et TL Ming Leaves. Chromatographia. 2008. Vol. 68 (11-12). P. 955-960. DOI: 10.1365/s10337-008-0842-9.
Singh VK. Physiological and biochemical changes with special reference to mangiferin and oxidative enzymes level in malformation resistant and susceptible cultivars of mango (Mangifera indica L.). Scientia Horticulturae. 2006. Vol. 108 (1) P. 43-48. DOI: 10.1016/j.scienta.2006.01.007.
Pardo-Andreu GL, Philip SJ, Riano A et al. Mangifera indica L. (Vimang) protection against serum oxidative stress in elderly humans. Archives of Medical Research. 2006. Vol. 37 (1). P. 158-164. DOI: 10.1016/j.arcmed.2005.04.017.
Sun QH, Sun AL, Liu RM. Preparative isolation and purification of four compounds from the Chinese medicinal herb Rhizoma Anemarrhenae by high-speed counter-current chromatography. Journal of Chromatography A. 2006. Vol. 1104 (1-2). P. 69-74. DOI: 10.1016/j.chroma.2005.11.046.
Islam MN, Yoo HH, Lee J et al. Simultaneous Determination of Bioactive Xanthone Glycosides and Norlignans from Ethanolic Extract of Anemarrhena asphodeloides by Liquid Chromatography. Journal of AOAC International. 2008.Vol. 91 (6). P. 1271-1277.
Matkowski A, Ku P, Janda B et al. Isolation and antioxidant activity evaluation of mangiferin from Belamcandae rhizoma. Acta Biochimica Polonica. 2009. Vol. 56 (S3). P. 14-15.
Wagner H, Bauer R, Melchart D et al. Chromatographic Fingerprint Analysis of Herbal Medicines. Springer Vienna, 2011. P 127-139.
Мykhailenko O, Chetvernya S, Bezruk I et al. Bioactive constituents of Iris hybrida (Iridaceae): Processing effect. Biomedical Chromatography. 2022. Vol. 36 (7). P. e5369. DOI: https://doi.org/10.1002/bmc.5369.
Mykhailenko O, Buydin Y, Ivanauskas L et al. Innovative GACP Approaches for Obtaining the Quality Iris hybrida Leaves for the Pharmaceutical Industry. Chem. Biodiversity. 2022. Vol. 19 (4). P. e202200149. DOI: 10.1002/cbdv.202200149.
Meszaros S. Evolutionary Significance of Xanthones in Gentianaceae - a Reappraisal. Biochemical Systematics and Ecology. 1994. Vol. 22 (1). P. 85-94. DOI: 10.1016/0305-1978(94)90118-X.
Kitanov GM, Nedialkov PT. Mangiferin and isomangiferin in some Hypericum species. Biochemical Systematics and Ecology. 1998.Vol. 26 (6). P. 647-653.
Karunanayake EH, Sirimanne SR. Mangiferin from the Root Bark of Salacia Reticulata. Journal of Ethnopharmacology. 1985. Vol. 13 (2). P. 227-228. DOI: 10.1016/0378-8741(85)90010-8.
Shastry V, Haldankar A, Kadam N. HPLC Estimation of Mangiferin in Salacia chinensis Linn. Asian Journal of Chemistry. 2009.Vol. 21 (9). P. 6679-6682.
Alhazimi HMG. Miana GA. Naturally Occurring Xanthones in Higher-Plants and Ferns. Journal of the Chemical Society of Pakistan. 1990. Vol. 12 (2). P. 174-188.
Talamond P, Conejero G, Verdeil JL, Poessel JL. Isolation of Cglycosyl Xanthones from Coffea pseudozanguebariae and Their Location. Natural Product Communications. 2011. Vol. 6 (12). P. 1885-1888.
Talamond P, Mondolot L, Gargadennec A et al. First report on mangiferin (Cglucosyl-xanthone) isolated from leaves of a wild coffee plant, Coffea pseudozanguebariae (Rubiaceae). Acta Botanica Gallica. 2008. Vol. 155 (4). P. 513-519.
Augustyn WA, Combrinck S, Botha BM. Comparison of mangiferin in mango leaf and honeybush infusions. Planta Medica. 2011. Vol. 77 (12). P. 1326-1326. DOI: 10.1055/s-0031-1282469.
van der Merwe JD, Joubert E, Richards ES et al. A comparative study on the antimutagenic properties of aqueous extracts of Aspalathus linearis (rooibos), different Cyclopia spp. (honeybush) and Camellia sinensis teas. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2006. Vol. 611 (1-2). P. 42-53. DOI: 10.1016/j.mrgentox.2006.06.030.
Joubert E, Otto F, Gruner S, Weinreich B. Reversed-phase HPLC determination of mangiferin, isomangiferin and hesperidin in Cyclopia and the effect of harvesting date on the phenolic composition of C. genistoides. European Food Research and Technology. 2003. Vol. 216 (3). P. 270-273.
Kokotkiewicz A, Luczkiewicz M. Honeybush (Cyclopia sp.) - A rich source of compounds with high antimutagenic properties. Fitoterapia. 2009. Vol. 80 (1). P. 3-11. DOI: 10.1016/j.fitote.2008.11.001.
Chen YH, Chang FR, Lin YJ et al. Identification of antioxidants from rhizome of Davallia solida. Food Chemistry. 2008. Vol. 107 (2). P. 684-691. DOI: 10.1016/j.foodchem.2007.08.066.
de Beer D, Joubert E. Development of HPLC method for Cyclopia subternata phenolic compound analysis and application to other Cyclopia spp. Journal of Food Composition and Analysis. 2010. Vol. 23 (3). P. 289-297. DOI: 10.1016/j.jfca.2009.10.006.
Kim W-J, Veriansyah B, Lee Y-W et al. Extraction of mangiferin from Mahkota Dewa (Phaleria macrocarpa) using subcritical water. Journal of Industrial and Engineering Chemistry. 2010. Vol. 16 (3). P. 425-430. DOI: 10.1016/j.jiec.2009.08.008.
Vyas A, Syeda K, Ahmad A et al. Perspectives on Medicinal properties of Mangiferin. Mini Rev.Med. Chem. 2012. Vol. 12 (5). P. 412-425. DOI: 10.2174/138955712800493870.
Sethiya NK, Trivedi A, Patel MB, Mishra SH. Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India. J.Adv. Pharmaceut. Tech. Res. 2010. Vol. 1 (4). P. 388-395. DOI: 10.4103/0110-5558.76437.
Dineshkumar B, Mitra A, Manjunatha M. Studies on theanti-diabetic and hypolipidemic potentials of mangiferin (Xanthone Glucoside) in streptozotocin-induced Type 1 and Type 2 diabetic model rats. Int. J. Adv. Pharmaceut. Sci. 2010. Vol. 1. P. 75-85. DOI: 10.5138/ijaps.2010.0976.1055.01009.
Singh SK, Kumar Y, Kumar SS et al. Antimicrobial Evaluation of Mangiferin Analogues. Ind. J. Pharm. Sci. 2009. Vol. 71 (3). P. 328-331. DOI: 10.4103/0250-474X.56023.
Luo F, Lv Q, Zhao Y et al. Quantification and Purification of Mangiferin from Chinese Mango (Mangifera indica L.) Cultivars and Its Protective Effect on Human Umbilical Vein Endothelial Cells under H(2)O(2)-induced Stress. Intl. J. Mol. Sci. 2012. Vol. 13 (9). P. 11260-11274. DOI: 10.3390/ijms130911260.
Jyotshna, Srivastava P, Killadi B, Shanker K. Unidimensional double development HPTLC-densitometry method for simultaneous analysis of mangiferin and lupeol content in mango (Mangifera indica) pulp and peel during storage. Food Chem. 2015. Vol. 176. P. 91-98. DOI: 10.1016/j.foodchem.2014.12.034.
Sethiya NK, Nahata A, Dixit VK. Comparative thin layer chromatographic investigations on commercial sources of Shankhpushpi in India. Pharmacog. J. 2009. Vol. 1 (3). P. 224-226.
Lucchesi ME, Chemat F, Smadja J. Solvent –free microwave extraction of essential oils from aromatic herbs; comparison with conventional hydro-distillation. J Chromatogr. 2004. Vol. 1043. P. 323-327. DOI: 10.1016/j.chroma.2004.05.083.
Singh SK, Tiwari RM, Sinha SK et al. Antimicrobial evaluation of mangiferin and its synthesized analogues. Asian Pacific Journal of Tropical Biomedicine. 2012. Vol. 2 (2). P. S884-S887. DOI: 10.1016/S2221-1691(12)60329-3.
Salomon S, Sevilla I, Betancourt R et al. Extraction of mangiferin from Mangifera indica L. leaves using microwave assisted Technique. Emir. J Food Agric. 2014. Vol. 26 (7). P. 616-622. DOI: 10.9755/ejfa.v26i7.18188.
Barreto J, Trevisan M, Hull W et al. Characterization and Quantitation of Polyphenolic Compounds in Bark, Kernel, Leaves, and Peel of Mango (Mangifera indica L.). Journal of agricultural and food chemistry. 2008. Vol. 56. P. 5599-5610. DOI: 10.1021/jf800738r.
Zou T-B, Xia E-Q, He T-P et al. Ultrasound-Assisted Extraction of Mangiferin from Mango (Mangifera indica L.) Leaves Using Response Surface Methodology. Molecules. 2014. Vol. 19 (2). P. 1411–1421. DOI: 10.3390/molecules19021411.
Zou T-B, Wu H, Li H et al. Comparison of microwave-assisted and conventional extraction of mangiferin from mango (Mangifera indica L.) leaves. J. Sep. Sci. 2013. Vol. 36. P. 3457–3462. DOI: 10.1002/jssc.201300518.
Prado IM, Prado GHC, Prado JM, Meireles MAA. Supercritical CO2 and low-pressure solvent extraction of mango (Mangifera indica) leaves: Global yield, extraction kinetics, chemical composition and cost of manufacturing. Food Bioprod. Process. 2013. Vol. 91. P. 656–664. DOI: 10.1016/j.fbp.2013.05.007.
Lerma-Torres JM, Navarro-Ocaña A, Calderón-Santoyo M et al. Preparative scale extraction of mangiferin and lupeol from mango (Mangifera indica L.) leaves and bark by different extraction methods. J Food Sci Technol. 2019. Vol. 56 (10). P. 4625-4631. DOI: 10.1007/s13197-019-03909-0.
Ruiz-Montañez G, Ragazzo-Sánchez JA, Calderón-Santoyo M et al. Evaluation of extraction methods for preparative scale obtention of mangiferin and lupeol from mango peels (Mangifera indica L.). Food Chem. 2014. Vol. 159. P. 267-272. DOI: 10.1016/j.foodchem.2014.03.009.
Aspé E, Fernández K. The effect of different extraction techniques on extraction yield, total phenolic, and anti-radical capacity of extracts from Pinus radiata Bark. Industrial crops and products. 2011. Vol. 34 (1). P. 838-844. DOI: 10.1016/j.indcrop.2011.02.002.
Stoilova I, Gargova S, Stoyanova A, Ho L. Antimicrobial and antioxidant activity of the polyphenol mangiferin. Herba Pol. 2005. Vol. 51. P. 37-44.
Perrucci S, Fichi G, Buggiani C et al. Efficacy of mangiferin against Cryptosporidium parvum in a neonatal mouse model. Parasitol Res. 2006. Vol. 99. P. 184-188. DOI: 10.1007/s00436-006-0165-4.
Guha S, Ghosal S, Chattophadhyay U. Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy. 1996. Vol. 42 (6). P. 443-451. DOI: 10.1159/000239478.
Rajendran P, Ekambaram G, Sakthisekaran D. Protective role of mangiferin against benzo(a)pyrene induced lung carcinogenesis in experimental animals. Biol Pharm Bull. 2008. Vol. 31 (6). P. 1053-1058. DOI: 10.1248/bpb.31.1053.
Sarkar A, Sreenivasan Y, Ramesh GT, Manna SK. Beta-D-Glucoside suppresses tumor necrosis factorinduced activation of nuclear transcription factor kB but potentiates apoptosis. J Biol Chem. 2004. Vol. 279 (32). P. 33768-33781. DOI: 10.1074/jbc.M403424200.
Leiro JM, Alvarez E, Arranz JA et al. In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem Pharmacol. 2003.Vol. 65 (8). P. 1361-1371. DOI: 10.1016/s0006-2952(03)00041-8.
F, Fernandez A, Bishop K. Mangiferin and cancer: mechanisms of action. Nutrients. 2016. Vol. 8 (7). P. 396. DOI: 10.3390/nu8070396.
Wang RR, Gao YD, Ma CH et al. Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains. Molecules. 2011. Vol. 16 (5). P. 4264-4277. DOI: 10.3390/molecules16054264.
Rechenchoski D, Galhardi L, Cunha A et al. Antiviral potential of mangiferin against poliovirus. International Journal of Pharmacological Research. 2018. Vol. 8. P. 34. DOI: 10.7439/ijpr.v8i4.4706.
Muruganandan S, Srinivasan K, Gupta S et al. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol. 2005. Vol. 97 (3). P. 497-501. DOI: 10.1016/j.jep.2004.12.010.
Sellamuthu PS, Muniappan BP, Perumal SM, Kandasamy M. Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci. 2009. Vol. 55 (2). P. 206-214. DOI: 10.1248/jhs.55.206.
Saleh S, El-Maraghy N, Reda E, Barakat W. Modulation of diabetes and dyslipidemia in diabetic insulin-resistant rats by mangiferin: Role of adiponectin and TNF-α. An Acad Bras Cienc. 2014. Vol. 86 (4). P. 1935-1948. DOI: 10.1590/0001-3765201420140212.
Joubert E, Richards ES, van der Merwe JD et al. Effect of species variation and processing on phenolic composition and in vitro antioxidant activity of aqueous extracts of Cyclopia spp. (honeybush tea). J. Agri. Food Chem. 2008. Vol. 56 (3). P. 954-963. DOI: 10.1021/jf072904a.
Pauletti PM, Castro-Gamboa I, Silva DHS et al. New antioxidant Cglucosylxanthones from the stems of Arrabidaea samydoides. Journal of Natural Products. 2003. Vol. 66 (10). P. 1384-1387. DOI: 10.1021/np030100t.
Ghosh M, Das J, Sil PC. D(+) galactosamine induced oxidative and nitrosative stress-mediated renal damage in rats via NF-kappa B and inducible nitric oxide synthase (iNOS) pathways is ameliorated by a polyphenol xanthone, mangiferin. Free Radical Research. 2012. Vol. 46 (2). P. 116-132. DOI: 10.3109/10715762.2011.644240.
García D, Escalante M, Delgado R et al. Anthelminthic and antiallergic activities of Mangifera indica L. stem bark components Vimang and mangiferin. Phytother Res. 2003. Vol. 17. P. 1203-1208. DOI: 10.1002/ptr.1343.
Rivera DG, Balmaseda IH, León AA et al. Anti-allergic properties of Mangifera indica L. extract (Vimang) and contribution of its glucosylxanthone mangiferin. J Pharm Pharmacol. 2006. Vol. 58 (3). P. 385-392. DOI: 10.1211/jpp.58.3.0014.
Telang M, Dhulap S, Mandhare A, Hirwani R. Therapeutic and cosmetic applications of mangiferin: A patent review. Expert Opin Ther Pat. 2013. Vol. 23 (12). P. 1561-1580. DOI: 10.1517/13543776.2013.836182.
Garrido G, González D, Lemus Y et al. In vivo and in vitro antiinflammatory activity of Mangifera indica L. extract (Vimang®). Pharmacol Res. 2004. Vol. 50 (2). P. 143-149. DOI: 10.1016/j.phrs.2003.12.003.
Saha S, Sadhukhan P, Sil PC. Mangiferin: A xanthonoid with multipotent anti inflammatory potential. Biofactors. 2016. Vol. 42 (5). P. 459 474. DOI: 10.1002/biof.1292.
Dar A, Faizi S, Naqvi S et al. Analgesic and antioxidant activity of mangiferin and its derivatives: The structure activity relation-ship. Biol Pharm Bull. 2005. Vol. 28 (4). P. 596-600. DOI: 10.1248/bpb.28.596.
Duang XY, Wang Q, Zhou XD, Huang DM. Mangiferin: A possible strategy for periodontal disease to therapy. Med Hypotheses. 2011. Vol. 76 (4). P. 486-488. DOI: 10.1016/j.mehy.2010.11.029.
Garrido-Suárez BB, Garrido G, Delgado R et al. A Mangifera indica L. extract could be used to treat neuropathic pain and implication of mangiferin. Molecules. 2010. Vol. 15 (12). P. 9035-9045. DOI: 10.3390/molecules15129035.
Pokorski M. Mangiferin - A Nutraceutical with Clinical Implications. Vitam Miner. 2013. Vol. 3. P. e122.
Makare N, Bodhankar S, Rangari V. Immunomodulatory activity of alcoholic extract of Mangifera indica Linn. in mice. J. Ethnopharmacol. 2001. Vol. 78 (2-3). P. 133–137. DOI: 10.1016/s0378-8741(01)00326-9.
Jagetia GC, Venkatesha VA. Mangiferin protects human peripheral blood lymphocytes against γ-radiation–induced DNA strand breaks: a fluorescence analysis of DNA unwinding assay. Nutrition Research. 2006. Vol. 26 (6). P. 303-311. DOI: 10.1016/j.nutres.2006.06.011.
Rodríguez J, Di Pierro D, Gioia M et al. Effects of a natural extract from Mangifera indica L, and its active compound, mangiferin, on energy state and lipid peroxidation of red blood cells. Biochim Biophys Acta. 2006. Vol. 1760 (9). P. 1333–1342. DOI: 10.1016/j.bbagen.2006.04.005.
Wilkinson A, Monteith G, Shaw P et al. Effects of the Mango Components Mangiferin and Quercetin and the Putative Mangiferin Metabolite Norathyriol on the Transactivation of Peroxisome Proliferator-Activated Receptor Isoforms. Journal of agricultural and food chemistry. 2008. Vol. 56. P. 3037-3042. DOI: 10.1021/jf800046n.
Sekar V, Mani S, Malarvizhi R et al. Positive interaction of mangiferin with selected oral hypoglycemic drugs: A therapeutic strategy to alleviate diabetic nephropathy in experimental rats. Mol. Biol. Rep. 2020. Vol. 47 (6). P. 4465–4475. DOI: 10.1007/s11033-020-05517-0.
Wang X, Gao L, Lin H et al. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli. Eur. J. Pharmacol. 2018. Vol. 824. P. 170-178. DOI: 10.1016/j.ejphar.2018.02.009.
Sellamuthu PS, Arulselvan P, Muniappan BP, Kandasamy M. Effect of mangiferin isolated from Salacia chinensis regulates the kidney carbohydrate metabolism in streptozotocin–induced diabetic rats. Asian Pac. J. Trop. Biomed. 2012. Vol. 2 (3). P. S1583–S1587. DOI: 10.1016/S2221-1691(12)60457-2.
Rajendran P, Rengarajan T, Nishigaki Y et al. In vitro studies on mangiferin protection against cadmium-induced human renal endothelial damage and cell death via the MAP kinase and NF-j B pathways. J. Recept. Signal Transduct. Res. 2016. Vol. 36 (1). P. 57–66. DOI: 10.3109/10799893.2015.1019137.
Walia V, Chaudhary SK, Sethiya NK. Therapeutic Potential of Mangiferin in the Treatment of Various Neuropsychiatric and Neurodegenerative Disorders. Neurochem Int. 2020. Vol. 143. P. 104939. DOI: 10.1016/j.neuint.2020.104939.
Wang B, Wan J, Gong X et al. Mangiferin attenuates renal ischemia-reperfusion injury by inhibiting inflammation and inducing adenosine production. Int. Immunopharmacol. 2015. Vol. 25 (1). P. 148–154. DOI: 10.1016/j.intimp.2014.11.011.
Saha S, Sadhukhan P, Sinha K et al. Mangiferin attenuates oxidative stress induced renal cell damage through activation of PI3K induced Akt and Nrf-2 mediated signaling pathways. Biochem. Biophys. Rep. 2016. Vol. 5. P. 313–327. DOI: 10.1016/j.bbrep.2016.01.011.
Sahu AK, Verma VK, Mutneja E et al. Mangiferin attenuates cisplatin-induced acute kidney injury in rats mediating modulation of MAPK pathway. Mol. Cell. Biochem. 2019. Vol. 452 (1-2). P. 141–152. DOI: 10.1007/s11010-018-3420-y.
He L, Peng X, Zhu J et al. Mangiferin attenuate sepsis-induced acute kidney injury via antioxidant and anti-inflammatory effects. Am. J. Nephrol. 2014. Vol. 40 (5). P. 441–450. DOI: 10.1159/000369220.
Lum P, Sekar M, Gan S et al. Therapeutic Potential of Mangiferin against Kidney Disorders and its Mechanism of Action: A Review. Saudi Journal of Biological Sciences. 2022. Vol. 29 (3). P. 1530-1542. DOI: 10.1016/j.sjbs.2021.11.016.
Feng ST, Wang ZZ, Yuan YH et al. Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models. Pharmacol Res. 2019. Vol. 146. P. 104336. DOI: 10.1016/j.phrs.2019.104336.
Sethiya NK, Mishra SH. Investigation of mangiferin, as a promising natural polyphenol xanthone on multiple targets of Alzheimer’s disease. Journal of Biologically Active Products from Nature. 2014. Vol. 4 (2). P. 110-119. DOI: 10.1080/22311866.2014.921121.
Márquez L, García-Bueno B, Madrigal JL, Leza JC. Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur J Nutr. 2012. Vol. 51 (6). P. 729-739. DOI: 10.1007/s00394-011-0252-x.
Rajendran P, Rengarajan T, Nandakumar N et al. Mangiferin in cancer chemoprevention and treatment: pharmacokinetics and molecular targets. J Recept Signal Transduct Res. 2015. Vol. 35 (1). P. 76–84. DOI: 10.3109/10799893.2014.931431.
Xiao J, Liu L, Zhong Z et al. Mangiferin regulates proliferation and apoptosis in glioma cells by induction of microRNA-15b and inhibition of MMP-9 expression. Oncol Rep. 2015. Vol. 33 (6). P. 2815–2820. DOI: 10.3892/or.2015.3919.
Hu X, Moscinski LC. Cdc2: A monopotent or pluripotent CDK? Cell Prolif. 2011. Vol. 44 (3). P. 205-211. DOI: 10.1111/j.1365-2184.2011.00753.x.
Peng ZG, Yao YB, Yang J et al. Mangiferin induces cell cycle arrest at G2/M phase through ATR-Chk1 pathway in HL-60 leukemia cells. Genet Mol Res. 2015. Vol. 14 (2). P. 4989-5002. DOI: 10.4238/2015.May.12.2.
Yao YB, Peng ZG, Liu ZF et al. Effects of mangiferin on cell cycle status and CDC2/Cyclin B1 expression of HL-60 cells. Zhong Yao Cai. 2010. Vol. 33 (1). P. 81-85.
du Plessis-Stoman D, du Preez J, van de Venter M. Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFκB in cancer cell lines. Afr J Tradit Complement Altern Med. 2011. Vol. 8 (2). P. 177-184. DOI: 10.4314/ajtcam.v8i2.63206.
Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Archiv. 2005. Vol. 446 (5). P. 475-482. DOI: 10.1007/s00428-005-1264-9.
Shi W, Deng J, Tong R et al. Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells. Mol Med Rep. 2016. Vol. 13 (4). P. 3423-3432. DOI: 10.3892/mmr.2016.4947.
Lv J, Wang Z, Zhang L et al. Mangiferin induces apoptosis and cell cycle arrest in MCF-7 cells both in vitro and in vivo. J Anim Vet Adv. 2013. Vol. 12 (3). P. 352-359. DOI: 10.3923/javaa.2013.352-359.
Zou B, Wang H, Liu Y et al. Mangiferin induces apoptosis in human ovarian adenocarcinoma OVCAR3 cells via the regulation of Notch3. Oncol Rep. 2017. Vol. 38 (3). P. 1431-1441. DOI: 10.3892/or.2017.5814.
Dilshara M, Kang C-H, Choi Y-H, Gi Young K. Mangiferin inhibits tumor necrosis factor-?-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-?B activity. BMB reports. 2015. Vol. 48. DOI: 10.5483/BMBRep.2015.48.10.003.
Wei ZQ, Yan L, Deng JG, Deng J. Mangiferin protects rats against chronic bronchitis via regulating NF-kappaB (P65) and IkappaBalpha expression in mononuclear cells. Yao Xue Xue Bao. 2014. Vol. 49 (5). P. 596–601.
Prabhu S, Jainu M, Sabitha KE, Devi CS. Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. J Ethnopharmacol. 2006. Vol. 107 (1). P. 126-133. DOI: 10.1016/j.jep.2006.02.014.
Prabhu S, Jainu M, Sabitha KE, Shyamala Devi CS. Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats. Vascul Pharmacol. 2006. Vol. 44 (6). P. 519-525. DOI: 10.1016/j.vph.2006.03.012.
Prabhu S, Narayan S, Devi C. Mechanism of protective action of mangiferin on suppression of inflammatory response and lysosomal instability in rat model of myocardial infarction. Phytother Res. 2009. Vol. 23. P. 756-760. DOI: 10.1002/ptr.2549.
Zheng D, Hou J, Xiao Y et al. Cardioprotective effect of mangiferin on left ventricular remodeling in rats. Pharmacology. 2012. Vol. 90 (1-2). P. 78-87. DOI: 10.1159/000339450.
Arozal W, Suyatna FD, Juniantito V et al. The effects of mangiferin (Mangifera indica L) in doxorubicin-induced cardiotoxicity in rats. Drug Res (Stuttg). 2014. Vol. 65 (11). P. 574-580. DOI: 10.1055/s-0034-1394457.
Guo F, Huang C, Liao X et al Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol Nutr Food Res. 2011. Vol. 55 (12). P. 1809-1818. DOI: 10.1002/mnfr.201100392.
Yadav VP, Shukla A, Choudhury S et al. IL1β/ TNFα/COX-2/VEGF axis responsible for effective healing potential of C-glucoside xanthone (mangiferin) based ointment in immunocompromised rats. Cytokine. 2022. Vol. 158. P. 156012. DOI: 10.1016/j.cyto.2022.156012.
Pardo-Andreu GL, Sánchez-Baldoquín C, Avila-González R et al. Fe(III) improves antioxidant and cytoprotecting activities of mangiferin. Eur J Pharmacol. 2006. Vol. 547 (1-3). P. 31-36. DOI: 10.1016/j.ejphar.2006.07.040.
Jeong J-J, Jang S-E, Hyam SR et al. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-ΚB and MAPK pathways. Eur. J. Pharmacol. 2014. Vol. 740. P. 652–661. DOI: 10.1016/j.ejphar.2014.06.013.
Garrido-Suárez BB, Garrido G, Castro-Labrada M et al. Anti-hypernociceptive effect of mangiferin in persistent and neuropathic pain models in rats. Pharmacol. Biochem. Behav. 2014. Vol. 124. P. 311–319. DOI: 10.1016/j.pbb.2014.06.019.
Yoosook C, Bunyapraphatsara N, Boonyakiat Y, Kantasuk C. Antiherpes simplex virus activities of crude water extracts of Thai medicinal plants. Phytomedicine. 2000. Vol. 6 (6). P. 411-419. DOI: 10.1016/S0944-7113(00)80068-9.
Zheng MS, Lu ZY. Antiviral effect of mangiferin and isomangiferin on herpes simplex virus. Chin Med J. 1990. Vol. 103. P. 160-165.
Zhu XM, Song JX, Huang ZZ et al. Antiviral activity of mangiferin against herpes simplex virus type 2 in vitro. Acta Pharmacol Sin. 1993. Vol. 14 (5). P. 452-454.
Anand G, Ravinanthan M, Basaviah R, Shetty AV. In vitro antimicrobial and cytotoxic effects of Anacardium occidentale and Mangifera indica in oral care. J Pharm Bioallied Sci. 2015. Vol. 7. P. 69-74. DOI: 10.4103/0975-7406.148780.
Acosta J, Sevilla I, Salomón S et al. Determination of mangiferin solubility in solvents used in the biopharmaceutical industry. J. Pharmacy Pharmacognosy Res. 2016. Vol. 4 (2). P. 49–53.
van der Merwe DJ, Joubert E, Manley M et al. Mangiferin glucuronidation: important hepatic modulation of antioxidant activity. Food Chem. Toxicol. 2012. Vol. 50 (3–4). P. 808–815. DOI: 10.1016/j.fct.2011.11.018.
Han D, Chen C, Cong Z et al. Determination of mangiferin in rat plasma by liquid liquid extraction with UPLC-MS/MS. J Pharm Biomed Anal. 2010. Vol. 51 (1). P. 260-263. DOI: 10.1016/j.jpba.2009.07.021.
Tian X, Gao Y, Xu Z et al. Pharmacokinetics of mangiferin and its metabolite-norathyriol. Part 1: systemic evaluation of hepatic first-pass effect in vitro and in vivo. Biofactors. 2016. Vol. 42 (5). P. 533–544. DOI: 10.1002/biof.1291.
Tian X, Xu Z, Li Z et al. Pharmacokinetics of mangiferin and its metabolite-norathyriol, Part 2: influence of UGT, CYP450, P-gp, and enterobacteria and the potential interaction in Rhizoma Anemarrhenae decoction with timosaponin B2 as the major contributor. Biofactors. 2016. Vol. 42 (5). P. 545–555. DOI: 10.1002/biof.1290.
Louisa M, Soediro TM, Suyatna FD. In vitro modulation of P-glycoprotein, MRP-1 and BCRP expression by mangiferin in doxorubicin-treated MCF-7 cells. Asian Pac. J. Cancer Prev. 2014. Vol. 15 (4). P. 1639–1642. DOI: 10.7314/apjcp.2014.15.4.1639.
Ma H, Chen H, Sun L et al. Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia. 2014. Vol. 93. P. 54–61. DOI: 10.1016/j.fitote.2013.10.016.
Wang X, Gu Y, Ren T et al. Increased absorption of mangiferin in the gastrointestinal tract and its mechanism of action by absorption enhancers in rats. Drug Dev. Ind. Pharm. 2013. Vol. 39 (9). P. 1408–1413. DOI: 10.3109/03639045.2012.704043.
Liu H, Wu B, Pan G et al. Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats. Drug Metab. Dispos. 2012. Vol. 40 (11). P. 2109–2118. DOI: 10.1124/dmd.112.045849.
Khurana RK, Kaur R, Kaur M et al. Exploring and validating physicochemical properties of mangiferin through GastroPlus® software. Future Sci OA. 2017. Vol. 3 (1). P. FSO167. DOI: 10.4155/fsoa-2016-0055.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
